• 0 Posts
  • 79 Comments
Joined 1 year ago
cake
Cake day: June 13th, 2023

help-circle





  • I forget the specifics and who came up with it, but: pick an amount you haven’t written before. Then, write that much without looking back. If you can set your word processor to only keep your current line visible, even better. Once you’ve written that many paragraphs or pages, do a fast edit. Use a timer so you can’t linger. Then write that much again with the same strategy. After 3-5 times, do a more thorough edit of the whole thing.

    It’s not necessarily how you always want to write, but it can help getting over that initial confidence block as an exercise.




  • Great, and where local is the best choice they should do that. But nobody can seriously argue that reducing the ability of government to shop around for the best cost/quality balance is a good thing. It’s not like the only options are buy everything American or everything from China. I’d like qualified experts making that decision, not legislators.

    You create bad incentives if you artificially reduce competition like this. Not every good or service will have tons of American choices, so you end up with a handful of companies who know the government has no other choice.



  • I know someone who has a similar outlook (climate change is real but science will solve it, so we don’t need to change anything). Basically anything science produces toward that end they will move the goalpost and say it’s not worth pursuing because science will fix it.

    It is essentially their way of making climate change denialism seem reasonable and open-minded. I think if somebody came up with a miracle device to magically reverse everything, they’d complain it’s too costly at any price.









  • Two points about R&D costs:

    First, they aren’t just trying to make up what they spent on this treatment, but others that failed during research/trials. There’s a lot of them the general public will never hear about, and pharmas generally don’t like to bring attention to their failures. Part of that is many shareholders are morons who don’t understand how science works.

    Second, the costs can get fuzzier for larger companies who in-house much of the R&D process, since the costs get shared among many programs. Properly attributing spend in that case can be a serious challenge.

    All that said, they’ve clearly seen an opportunity to rake it in with this trendy drug and are charging way more than they need to.